ARMEN GARO H 4
4 · AGENUS INC · Filed May 5, 2026
Research Summary
AI-generated summary of this filing
Agenus (AGEN) CEO Garo H. Armen Receives Stock Award
What Happened Garo H. Armen — Chairman, Chief Executive Officer and Principal Financial Officer of Agenus Inc. (AGEN) — was issued 4,233 shares on May 1, 2026 as compensation (salary paid in stock). The shares were valued at $3.84 each based on the May 1, 2026 closing price, for a total of approximately $16,255. According to the filing, these shares were issued under the company’s 2019 Equity Incentive plan and were fully vested on the date of issuance.
Key Details
- Transaction type: Award / stock issuance (salary paid in stock)
- Transaction date: May 1, 2026; Filing date: May 5, 2026 (timely filed)
- Price used: $3.84 per share (closing price on May 1, 2026)
- Shares issued: 4,233; total value ≈ $16,255
- Shares are held in Dr. Armen’s IRA accounts (footnote)
- Additional holdings disclosed: Garo Armen 2020 2 Year AG GRAT holds 23,950 shares; Pixie Partners (general partnership where he is a general partner) owns 5,000 shares — he disclaims beneficial ownership to the extent of his pecuniary interest
- Shares were fully vested on issuance and were issued with Compensation Committee approval
Context This filing reflects routine compensation converted to equity rather than an open-market purchase or sale. Such salary-in-stock awards are common and do not necessarily indicate a buy/sell signal by the insider. The position and timing were disclosed promptly under Section 16 reporting requirements.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-05-01$3.84/sh+4,233$16,255→ 346,783 total
- 31,298(indirect: See Footnote)
Common Stock
[F3] - 28,950(indirect: See Footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 1, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
- [F2]$3.84 is the closing price of our Common Stock on May 1, 2026, the last trading day for the payroll date for the pay period ending May 1, 2026.
- [F3]Shares are held in Dr. Armen's IRA accounts.
- [F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.